Rev Med Liege. 2006 Mar;61(3):201-5.

[Etanercept (Enbrel) for the treatment of moderate to severe plaque type psoriasis].

[Article in French]

Source

Service de Dermatopathologie, CHU du Sart Tilman, Liège. Claudine.Franchimont@ulg.ac.be

Abstract

Etanercept (Enbrel) is a soluble tumour necrosis factor (TNF) receptor drug. By this mechanism, it inhibits the effects of TNF-alpha involved in the pathogenesis of psoriasis. Enbrel is approved for the treatment of moderate to severe chronic plaque psoriasis, and also for psoriatic arthritis.

PMID:: 16681009; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Medical

Psoriasis - MedlinePlus Health Information

Molecular Biology Databases

Etanercept - HSDB

Supplemental Content

Save items

Related citations in PubMed

Review Etanercept: a review of its use in the management of plaque psoriasis and psoriatic arthritis. [Am J Clin Dermatol. 2005]
Review Etanercept: a review of its use in the management of plaque psoriasis and psoriatic arthritis.
Goldsmith DR, Wagstaff AJ. Am J Clin Dermatol. 2005; 6(2):121-36.
Review Spotlight on etanercept in plaque psoriasis and psoriatic arthritis. [BioDrugs. 2005]
Review Spotlight on etanercept in plaque psoriasis and psoriatic arthritis.
Goldsmith DR, Wagstaff AJ. BioDrugs. 2005; 19(6):401-3.
Review Etanercept for the treatment of psoriasis. [Skin Therapy Lett. 2006]
Review Etanercept for the treatment of psoriasis.
Bissonnette R. Skin Therapy Lett. 2006 Feb; 11(1):1-4.
Review Etanercept and efalizumab for the treatment of psoriasis: a systematic review. [Health Technol Assess. 2006]
Review Etanercept and efalizumab for the treatment of psoriasis: a systematic review.
Woolacott N, Hawkins N, Mason A, Kainth A, Khadjesari Z, Vergel YB, Misso K, Light K, Chalmers R, Sculpher M, et al. Health Technol Assess. 2006 Nov; 10(46):1-233, i-iv.
Review The treatment of psoriasis with etanercept. [Semin Cutan Med Surg. 2005]
Review The treatment of psoriasis with etanercept.
Strober BE. Semin Cutan Med Surg. 2005 Mar; 24(1):28-36.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Recent activity

Clear Turn Off Turn On

[Etanercept (Enbrel) for the treatment of moderate to severe plaque type psorias...
[Etanercept (Enbrel) for the treatment of moderate to severe plaque type psoriasis].
Rev Med Liege. 2006 Mar ;61(3):201-5.

PubMed
Once-daily evening administration of mometasone furoate in asthma treatment init...
Once-daily evening administration of mometasone furoate in asthma treatment initiation.
Ann Allergy Asthma Immunol. 2006 Apr ;96(4):533-40.

PubMed
Coordination of growth and division during the cell cycle of fission yeast.
Coordination of growth and division during the cell cycle of fission yeast.
Cold Spring Harb Symp Quant Biol. 1991 ;56:557-65.

PubMed
[Lights, art, science - action!].
[Lights, art, science - action!].
Hist Cienc Saude Manguinhos. 2005 ;12(Suppl):401-18.

PubMed
Concerted roles of cyclin A, cdc25+ mitotic inducer, and type 2A phosphatase in ...
Concerted roles of cyclin A, cdc25+ mitotic inducer, and type 2A phosphatase in activating the cyclin B/cdc2 protein kinase at the G2/M phase transition.
Cold Spring Harb Symp Quant Biol. 1991 ;56:503-13.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: